NYSE:BAXBaxter International Stock Price, Forecast & News

Baxter International's stock was trading at $77.97 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BAX stock has increased by 9.7% and is now trading at $85.50. View which stocks have been most impacted by Coronavirus.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 5 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Baxter International.

Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, July 23rd 2020. View our earnings forecast for Baxter International.

Baxter International Inc (NYSE:BAX) announced its earnings results on Thursday, April, 30th. The medical instruments supplier reported $0.82 EPS for the quarter, beating the Zacks' consensus estimate of $0.73 by $0.09. The medical instruments supplier had revenue of $2.80 billion for the quarter, compared to analysts' expectations of $2.74 billion. Baxter International had a return on equity of 22.70% and a net margin of 8.85%. The business's revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.76 earnings per share. View Baxter International's earnings history.

Baxter International declared a quarterly dividend on Tuesday, May 5th. Shareholders of record on Friday, June 5th will be given a dividend of $0.245 per share on Wednesday, July 1st. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.15%. The ex-dividend date of this dividend is Thursday, June 4th. This is an increase from Baxter International's previous quarterly dividend of $0.22. View Baxter International's dividend history.

Baxter International declared that its board has authorized a share buyback program on Tuesday, November 13th 2018, which permits the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy up to 6.1% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board believes its shares are undervalued.

20 Wall Street analysts have issued 12-month price objectives for Baxter International's stock. Their forecasts range from $84.00 to $105.00. On average, they expect Baxter International's share price to reach $96.60 in the next twelve months. This suggests a possible upside of 13.0% from the stock's current price. View analysts' price targets for Baxter International.

Headlines about BAX stock have been trending negative on Wednesday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Baxter International earned a daily sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news about Baxter International.

Baxter International saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 4,030,000 shares, an increase of 31.3% from the June 15th total of 3,070,000 shares. Based on an average daily trading volume, of 3,100,000 shares, the short-interest ratio is presently 1.3 days. Approximately 0.8% of the shares of the stock are sold short. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Steris (STE), Insulet (PODD) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Honeywell International (HON), Cisco Systems (CSCO), AT&T (T), Pfizer (PFE), BlackRock (BLK), Verizon Communications (VZ), Abbott Laboratories (ABT) and Procter & Gamble (PG).

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International's stock is owned by a number of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.03%), Tsfg LLC (0.02%), Diversified Trust Co (0.01%), M&R Capital Management Inc. (0.00%), Private Trust Co. NA (0.00%) and Fulton Bank N. A. (0.00%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp. View institutional ownership trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Private Trust Co. NA, Fulton Bank N. A., and M&R Capital Management Inc.. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, and John D Forsyth. View insider buying and selling activity for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including Tsfg LLC, and Diversified Trust Co. View insider buying and selling activity for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $85.50.

Baxter International has a market capitalization of $43.37 billion and generates $11.36 billion in revenue each year. The medical instruments supplier earns $1.00 billion in net income (profit) each year or $3.31 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.

The official website for Baxter International is www.baxter.com.

Baxter International's mailing address is One Baxter Parkway DF2-1W, Deerfield IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]